Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regulatory T Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01446484
What this trial is testing

Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

Who this might be right for
End-Stage Renal DiseaseKidney Failure
Pirogov Russian National Research Medical University 30
Early research (Phase 1)Looking for participantsNCT05241444
What this trial is testing

CD4^LVFOXP3 in Participants With IPEX

Who this might be right for
IPEX
Bacchetta, Rosa, MD 30
Not applicableStudy completedNCT03385850
What this trial is testing

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis

Who this might be right for
SepsisImmune System DisorderEnteral Feeding
Nanjing First Hospital, Nanjing Medical University 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576699
What this trial is testing

CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

Who this might be right for
Steroid Refractory Graft Versus Host Disease
Cellenkos, Inc. 12
Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)Study completedNCT00314093
What this trial is testing

RFT-5-dgA in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Texas Southwestern Medical Center 41
Not applicableUnknownNCT01668381
What this trial is testing

Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06901102
What this trial is testing

Effect of Bee Venom on Chronic Kidney Disease-Mineral Bone Disorders in Hemodialysis Patients: a Randomized Controlled Trial

Who this might be right for
Chronic Kidney DiseaseBee VenomHemodialysis
Mansoura University 60
Testing effectiveness (Phase 2)Study completedNCT04065672
What this trial is testing

Low-dose IL-2 Treatment on Behcet's Disease

Who this might be right for
Behcet's Disease
HeJing 60
Not applicableNot Yet RecruitingNCT06997133
What this trial is testing

Sucralose as a Way to Enhance Regulatory T Cells

Who this might be right for
Healthy Volunteer
Caroline Lamarche 10
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Early research (Phase 1)Ended earlyNCT02846883
What this trial is testing

Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms

Who this might be right for
Abdominal Aortic Aneurysm
VA Office of Research and Development 28
Early research (Phase 1)Study completedNCT03556007
What this trial is testing

NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Nektar Therapeutics 48
Early research (Phase 1)Looking for participantsNCT06991361
What this trial is testing

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Who this might be right for
Graft Versus Host Disease (cGvHD)
Leslie Kean 21
Testing effectiveness (Phase 2)Study completedNCT01862120
What this trial is testing

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Assistance Publique - Hôpitaux de Paris 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05234190
What this trial is testing

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Who this might be right for
Rejection; Transplant, LiverLiver FailureLiver Diseases
Quell Therapeutics Limited 33
Post-approval studies (Phase 4)Active Not RecruitingNCT05325073
What this trial is testing

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

Who this might be right for
Liver Transplant Rejection
Northwestern University 9
Not applicableStudy completedNCT02963402
What this trial is testing

Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab

Who this might be right for
Arthritis,Rheumatoid
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 35
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Not applicableStudy completedNCT01064219
What this trial is testing

Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells

Who this might be right for
Infertility
The Egyptian IVF-ET Center 20
Next Page